The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series.
Publication
, Journal Article
Brayo, P; Hartsell, FL; Skeen, M; Morgenlander, J; Eckstein, C; Shah, S
Published in: J Neuroimmunol
December 15, 2019
OBJECTIVES: To describe the clinical presentation of MOG antibody disease (MOG-AD) in a series of patients at a single academic center. METHODS: We performed a retrospective review of patients with MOG antibodies. RESULTS: We review the clinical presentation of 11 patients with MOG antibodies. In patients seen at Duke University Health System with MOG antibodies, the most common presentation was optic neuritis. Rituximab was the most used treatment for long-term management. CONCLUSIONS: Our case series highlights the common presentation of MOG antibody disease (MOG-AD) at a single academic medical center.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Neuroimmunol
DOI
EISSN
1872-8421
Publication Date
December 15, 2019
Volume
337
Start / End Page
577078
Location
Netherlands
Related Subject Headings
- Treatment Outcome
- Rituximab
- Retrospective Studies
- Optic Neuritis
- Neurology & Neurosurgery
- Myelin-Oligodendrocyte Glycoprotein
- Middle Aged
- Male
- Immunologic Factors
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Brayo, P., Hartsell, F. L., Skeen, M., Morgenlander, J., Eckstein, C., & Shah, S. (2019). The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series. J Neuroimmunol, 337, 577078. https://doi.org/10.1016/j.jneuroim.2019.577078
Brayo, Petra, F Lee Hartsell, Mark Skeen, Joel Morgenlander, Christopher Eckstein, and Suma Shah. “The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series.” J Neuroimmunol 337 (December 15, 2019): 577078. https://doi.org/10.1016/j.jneuroim.2019.577078.
Brayo P, Hartsell FL, Skeen M, Morgenlander J, Eckstein C, Shah S. The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series. J Neuroimmunol. 2019 Dec 15;337:577078.
Brayo, Petra, et al. “The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series.” J Neuroimmunol, vol. 337, Dec. 2019, p. 577078. Pubmed, doi:10.1016/j.jneuroim.2019.577078.
Brayo P, Hartsell FL, Skeen M, Morgenlander J, Eckstein C, Shah S. The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series. J Neuroimmunol. 2019 Dec 15;337:577078.
Published In
J Neuroimmunol
DOI
EISSN
1872-8421
Publication Date
December 15, 2019
Volume
337
Start / End Page
577078
Location
Netherlands
Related Subject Headings
- Treatment Outcome
- Rituximab
- Retrospective Studies
- Optic Neuritis
- Neurology & Neurosurgery
- Myelin-Oligodendrocyte Glycoprotein
- Middle Aged
- Male
- Immunologic Factors
- Humans